Ptc Therapeutics (PTCT) Cash from Operations Growth (3y) (2015 - 2026)
Ptc Therapeutics (PTCT) Cash from Operations Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | - |
| 10 | Ptc Therapeutics | 6.47 Bn | 4.58 Bn | 244.52 Mn | -26.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.03% |
| Dec 31, 2025 | 40.89% |
| Sep 30, 2025 | -20.34% |
| Jun 30, 2025 | -1.83% |
| Mar 31, 2025 | 121.95% |
| Dec 31, 2024 | 24.18% |
| Sep 30, 2024 | -14.57% |
| Jun 30, 2024 | -31.89% |
| Mar 31, 2024 | 39.36% |
| Dec 31, 2023 | -15.93% |
| Sep 30, 2023 | -36.52% |
| Jun 30, 2023 | 42.64% |
| Mar 31, 2023 | 28.76% |
| Dec 31, 2022 | -153.35% |
| Sep 30, 2022 | -34.89% |
| Jun 30, 2022 | -21.87% |
| Mar 31, 2022 | -31.94% |
| Dec 31, 2021 | -65.66% |
| Sep 30, 2021 | -157.92% |
| Jun 30, 2021 | -2,081.64% |